LoginSignup
Neogen logo

Neogen Stock

StockStock
ISIN: US6404911066
Ticker: NEOG
US6404911066
NEOG

Price

Frequently asked questions

What is Neogen's market capitalization?

The market capitalization of Neogen is $3.32B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Neogen?

Neogen's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.109. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Neogen's stock?

Currently, 2 analysts cover Neogen's stock, with a consensus target price of $17.00. Analyst ratings provide insights into the stock's expected performance.

What is Neogen's revenue over the trailing twelve months?

Over the trailing twelve months, Neogen reported a revenue of $912.20M.

What is the EBITDA for Neogen?

Neogen's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $192.64M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Neogen?

Neogen has a free cash flow of -$124.88M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Neogen's stock?

The 5-year beta for Neogen is 1.23. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Neogen have, and what sector and industry does it belong to?

Neogen employs approximately 2,917 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Neogen's shares?

The free float of Neogen is 216.13M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $3.32B

5Y beta

 1.23

EPS (TTM)

 -$0.109

Free Float

 216.13M

Revenue (TTM)

 $912.20M

EBITDA (TTM)

 $192.64M

Free Cashflow (TTM)

 -$124.88M

Pricing

1D span
$14.82$15.52
52W span
$11.46$20.89

Analyst Ratings

The price target is $17.00 and the stock is covered by 2 analysts.

Buy

1

Hold

1

Sell

0

Information

Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Company’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.

2,917

Biotechnology & Drugs

Health Care

Identifier

ISIN

US6404911066

Primary Ticker

NEOG

Knockouts

Join the conversation
Sign upLogin